| TAZ functions as a tumor suppressor in multiple myeloma by downregulating MYC | None |
| The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZ. | liver, |
| TEADs mediate nuclear retention of TAZ to promote oncogenic transformation. | None |
| WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ. | None |
| Vgll1 interacts with TEAD4 in a manner similar to the transcription coactivators, as well as oncogenes YAP and TAZ, despite having a varied primary sequence. Vgll1 has the potential to promote cancer progression. | None |
| Structural and functional similarity between the Vgll1-TEAD and the YAP-TEAD complexes. | None |
| Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth. | None |